Literature DB >> 19681087

Lipopeptides from Staphylococcus aureus as Tlr2 Ligands: prediction with mrna expression, chemical synthesis, and immunostimulatory activities.

Yukari Fujimoto1, Masahito Hashimoto, Maiko Furuyashiki, Mami Katsumoto, Tsukasa Seya, Yasuo Suda, Koichi Fukase.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19681087     DOI： 10.1002/cbic.200900242

Source DB:  PubMed          Journal:  Chembiochem        ISSN： 1439-4227            Impact factor:   3.164


× No keyword cloud information.
  8 in total

1.  Vaccine Adjuvant Incorporation Strategy Dictates Peptide Amphiphile Micelle Immunostimulatory Capacity.

Authors:  Rui Zhang; Jake S Kramer; Josiah D Smith; Brittany N Allen; Caitlin N Leeper; Xiaolei Li; Logan D Morton; Fabio Gallazzi; Bret D Ulery
Journal:  AAPS J       Date:  2018-06-01       Impact factor: 4.009

Review 2.  Biomaterials for vaccine-based cancer immunotherapy.

Authors:  Rui Zhang; Margaret M Billingsley; Michael J Mitchell
Journal:  J Control Release       Date:  2018-10-09       Impact factor: 9.776

3.  Novel toll-like receptor 2 ligands for targeted pancreatic cancer imaging and immunotherapy.

Authors:  Amanda Shanks Huynh; Woo Jin Chung; Hyun-Il Cho; Valerie E Moberg; Esteban Celis; David L Morse; Josef Vagner
Journal:  J Med Chem       Date:  2012-11-08       Impact factor: 7.446

4.  The peptide sequence of diacyl lipopeptides determines dendritic cell TLR2-mediated NK activation.

Authors:  Masahiro Azuma; Ryoko Sawahata; Yuusuke Akao; Takashi Ebihara; Sayuri Yamazaki; Misako Matsumoto; Masahito Hashimoto; Koichi Fukase; Yukari Fujimoto; Tsukasa Seya
Journal:  PLoS One       Date:  2010-09-02       Impact factor: 3.240

5.  Type I Interferon-Independent Dendritic Cell Priming and Antitumor T Cell Activation Induced by a Mycoplasma fermentans Lipopeptide.

Authors:  Yohei Takeda; Masahiro Azuma; Kenji Funami; Hiroaki Shime; Misako Matsumoto; Tsukasa Seya
Journal:  Front Immunol       Date:  2018-03-14       Impact factor: 7.561

6.  Development of a vaccine based on bacteria-mimicking tumor cells coated with novel engineered toll-like receptor 2 ligands.

Authors:  Takashi Akazawa; Toshimitsu Ohashi; Viskam Wijewardana; Kikuya Sugiura; Norimitsu Inoue
Journal:  Cancer Sci       Date:  2018-04-22       Impact factor: 6.716

7.  Synthetic Lipopeptide Enhances Protective Immunity Against Helicobacter pylori Infection.

Authors:  Ruo-Yi Xue; Mu-Fei Guo; Ling Guo; Chang Liu; Sun Li; Jiao Luo; Li Nie; Lu Ji; Cong-Jia Ma; Da-Qun Chen; Si Sun; Zhe Jin; Quan-Ming Zou; Hai-Bo Li
Journal:  Front Immunol       Date:  2019-06-14       Impact factor: 7.561

8.  The second and third amino acids of Pam2 lipopeptides are key for the proliferation of cytotoxic T cells.

Authors:  Yohei Takeda; Masahiro Azuma; Ryoko Hatsugai; Yukari Fujimoto; Masahito Hashimoto; Koichi Fukase; Misako Matsumoto; Tsukasa Seya
Journal:  Innate Immun       Date:  2018-05-31       Impact factor: 2.680
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.